课题基金 / 基金详情

Pathogenesis of Alzheimer's disease by aberrant APP transport

Pathogenesis of Alzheimer's disease by aberrant APP transport
APP 转运异常导致阿尔茨海默病的发病机制
批准号:
20390018
负责人:
SUZUKI Toshiharu
金额:
$12.48万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2008
资助国家:
日本
项目状态:
已结题
起止时间:
2008 至 2010

项目摘要

项目成果

SUZUKI Toshiharu的其他基金

相似基金

相关文献

中文摘要
翻译
阿尔茨海默病的主要原因是β-淀粉样蛋白(Aβ)的产生和Aβ的神经毒性低聚物的形成。a β是淀粉样蛋白β-蛋白前体(APP)在β-和γ-分泌酶的连续作用下裂解而产生的代谢产物。γ-分泌酶的早老素成分突变可引起APP的膜内加工,导致Aβ的异常形成,进而导致家族性AD (FAD)。与FAD相比,散发性AD的主要病因尚不清楚。几种膜和跨膜蛋白与阿尔茨海默病有关,并且在阿尔茨海默病大脑中观察到囊泡运输系统的破坏,这表明膜运输系统的缺陷,包括轴突囊泡运输,可能是阿尔茨海默病发病的原始原因。我的研究重点是分析APP的囊泡贩运。APP是已知的激酶-1受体。我们之前的研究表明APP通过JIP1介导与KLC相关。此外,APP囊泡运输的中断增加了神经毒性Aβ的产生。然而,APP和激酶-1联合调控的分子机制尚不清楚。我们详细揭示了JIP1和KLC之间的关联,并提出了这种关联是如何调控的。
英文摘要
Major cause of Alzheimer's disease is production of β-amyloid (Aβ) and neurotoxic oligomer formation of Aβ. Aβ is a metabolic product generated by cleavage of the amyloid β-protein precursor (APP) by the successive action of β- and γ-secretases. Mutation in the presenilin component of γ-secretase can cause alternative intramembrane processing of APP, leading to aberrant speciation of Aβ, which, in turn, can lead to familial AD (FAD). In contrast to FAD, the primary cause of sporadic type of AD remains unclear. Several membrane and trnasmembrane proteins have been associated with AD, and the disruption of the vesicular transport system is observed in AD brains, suggesting that defects in the membrane trafficking system, including axonal vesicular transport, may be a primitive cause of AD pathogenesis. I focused this research on the analysis of APP vesicular trafficking. APP is known to cargo-receptor of kinesin-1. Our previous studies revealed that APP is associated to KLC through JIP1 mediation. Furthermore, disruption of APP vesicular transprort increased the generation of neurotoxic Aβ. However, the molecular mechanism how APP and kinesin-1 association is regulated remains unclear in detail. We revealed the association between JIP1 and KLC in detail and proposed how the association is regulated.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Lipids and Cellular Membranes in Amyloid Disease(Eds by Jelinek, R.)(Alzheimer's disease as a membrane-associated enzymopathy of β-amyloid precursor protein (APP) secretases ISBN:978-3-527-32860-4)
淀粉样蛋白疾病中的脂质和细胞膜(Jelinek, R. 编)(阿尔茨海默氏病是一种与 β-淀粉样前体蛋白 (APP) 分泌酶相关的膜相关酶病 ISBN:978-3-527-32860-4)
DOI: --
发表时间: 2011
期刊:
影响因子: --
作者: [Hata S., Saito Y., Suzuki T.]
通讯作者: Suzuki T.
Metabolic stabilization of p53 by FE65 in the nuclear matrix of osmotically stressed cells
FE65 在渗透应激细胞核基质中对 p53 的代谢稳定
DOI: --
发表时间: 2009
期刊: FEBS J. 276
影响因子: --
作者: [Nakaya, T., Kawai, T., Suzuki, T.]
通讯作者: T.
X11 proteins regulate the translocation of APP into detergent resistant membrane and suppress the amyloidogenic cleavage of APP by BACE in brain
X11 蛋白调节 APP 易位至抗去污剂膜并抑制大脑中 BACE 对 APP 的淀粉样蛋白裂解
DOI: --
发表时间: 2008
期刊: Journal of Biological Chemistry 283
影响因子: --
作者: [Saito, Y., Sano, Y., Vassar, R., Gandy, S., Nakaya, T., Yamamoto, T., and Suzuki, T.]
通讯作者: T.
Regulation of APP by phosphorylation and protein interactions
通过磷酸化和蛋白质相互作用调节 APP
DOI: --
发表时间: 2008
期刊: Journal of Biological Chemistry 283
影响因子: --
作者: [Suzuki, T. and Nakaya, T.]
通讯作者: T.
83
    Understanding for Alzheimer's disease pathogenesis involved in ApoE4 and X11L genes by large scale of expression analysis of genes
    • 批准号:
      16K14690
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2016
    • 负责人:
      SUZUKI Toshiharu
    • 依托单位:
    Understanding for Alzheimer's disease pathogenesis and the development of novel target for therapy
    • 批准号:
      26293010
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.73万
    • 财政年份:
      2014
    • 负责人:
      SUZUKI Toshiharu
    • 依托单位:
    Analyses of inhibitory effects of Inhibitory factor-1 on human ATP-synthase.
    Molecular mechanism of sporadic Alzheimer's disease onset
    • 批准号:
      23390017
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.9万
    • 财政年份:
      2011
    • 负责人:
      SUZUKI Toshiharu
    • 依托单位:
    国内基金
    海外基金
    基于单细胞和空间转录组分析APP-CD74在衰老泪腺中介导免疫微环境紊乱的机制研究
    • 批准号:
      2026JJ50085
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      王万鹏
    • 依托单位:
    基于GPX4/ACSL4铁死亡通路的 APP 基因突变调控 Aβ 代谢异常在阿尔茨海默病中的作用机制研究
    • 批准号:
      JCZRLH202600691
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    DDAH2在小胶质细胞中调控APP蛋白代谢的新机制及其在阿尔兹海默症中的作用
    • 批准号:
      2026JJ80535
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      李俊杰
    • 依托单位:
    APP细胞间信号介导癌症干细胞与肿瘤细胞的互作驱动肾癌干性特征和肿瘤发生发展的机制研究